Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele

Clinical Neurophysiology

Volumn 123, Issue 5, 2012, Pages 918-924

  Zamora, R ^a   Bartholow, J ^a   Green, E ^a,b   Morgan, C D ^a   Murphy, C ^a,b,c  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Metabolic syndrome; Olfactory event related potentials; Smell impairment

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; COGNITION; EVENT RELATED POTENTIAL; FEMALE; GENETIC RISK; GROUPS BY AGE; HETEROZYGOTE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; OBESITY; ODOR; OLFACTOMETER; OLFACTORY DISCRIMINATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SMELLING; WAIST CIRCUMFERENCE;

ADIPOSITY; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; BODY MASS INDEX; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; LINEAR MODELS; MALE; ODORS; OLFACTORY PATHWAYS; REACTION TIME; SMELL; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84858750283     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.09.001     Document Type: Article

References (69)

1. Braak H., Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992, 15(1-2):6-31.
2. Blum K., Sheridan P., Wood R., Braverman E., Chen T., Cull J., et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 1996, 89:396-400.
3. Cain W.S., Gent J., Catalanotto F.A., Goodspeed R.B. Clinical evaluation of olfaction. Am J Otolaryngol 1983, 4(4):252-256.
4. de Leon J., Diaz F., Josiassen R., Cooper T., Simpson G. Weight gain during a double-blind multidosage clozapine study. J Clin Psychopharmacol 2007, 27(1):22-27.
5. Donchin E., Coles M.G. Is the P300 component a manifestation of context updating?. Behav Brain Sci 1988, 11(3):357-427.
6. Duffy V., Backstrand J., Ferris A. Olfactory dysfunction and related nutritional risk in free-living, elderly women. J Am Diet Assoc 1995, 95(8):879-884.
7. Ferris A., Duffy V. Effect of olfactory deficits on nutritional status. Does age predict persons at risk?. Ann NY Acad Sci 1989, 561113-561123.
8. Green E., Jacobson A., Haase L., Murphy C. Reduced nucleus accumbens and amygdala activation to a pleasant taste is associated with obesity in older adults. Brain Res 2011, 1386:109-117.
9. Green J., Levey A. Event-related potential changes in groups at increased risk for Alzheimer disease. Arch Neurol 1999, 56(11):1398-1403.
10. Gunstad J., Lhotsky A., Wendell C., Ferrucci L., Zonderman A. Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010, 34(4):222-229.
11. Henderson V.W., Brinton R.D. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010, 182:77-96.
12. Ho A., Raji C., Becker J., Lopez O., Kuller L., Hua X., et al. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging 2010, 31(8):1326-1339.
13. Jun Ming W., Singh C., Lifei L., Irwin R.W., Shuhua C., Eun Ji C., et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2010, 107(14):6498-6503.
14. Juottonen K., Lehtovirta M., Helisalmi S., Riekkinen P.J., Soininen H. Major decrease in the volume of enthorhinal cortex in patients with Alzhiemer's disease carrying the apolipoprotien ε4 allele. J Neurosurg Psychiatry 1998, 65:322-327.
15. Kaplitt M., Gouras G.K., Makimura H., Jovanovic J., Sweeney D., Greengard P., et al. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications. Ann NY Acad Sci 1996, 802:42-49.
16. Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008, 32:1431-1437.
17. Kobal G., Hummel C. Cerebral chemosensory evoked potentials elicited by chemical stimulation of the human olfactory and respiratory nasal mucosa. Electroencephalogr Clin Neurophysiol 1988, 71(4):241-250.
18. Koster A., Leitzmann M., Schatzkin A., Mouw T., Adams K., van Eijk J., et al. Waist circumference and mortality. Am J Epidemiol 2008, 167(12):1465-1475.
19. Leddy J., Epstien L.H., Jaroni J.L., Roemmich J.N., Paluch R.A., Goldfield G.S. Influence of methylphenidate on eating in obese men. Obes Res 2004, 12(2):224-232.
20. Lee C., Carr M., Murdoch S., Mitchell E., Woods N., Wene M., et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab 2009, 94(4):1104-1110.
21. Lorig T.S. The application of electroencephalographic techniques to the study of human olfaction: a review and tutorial. Int J Psychophysiol 2000, 36(2):91-104.
22. Lorig T.S., Elmes D.G., Zald D.H., Pardo J.V. A computer-controlled olfactometer for fMRI and electrophysiological studies of olfaction. Behav Res Methods Instrum Comput 1999, 31(2):370-375.
23. Lorig T.S., Matia D.C., Peszka J.J., Bryant D.N. The effects of active and passive stimulation on chemosensory event-related potentials. Int J Psychophysiol 1996, 23:199-205.
24. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006, 103(15):5644-5651.
25. Malnick S., Knobler H. The medical complications of obesity. QJM: Monthly J Assoc Physicians 2006, 99(9):565-579.
26. Marsh J.T., Schubarth G., Brown W.S., Reige W., Strandburg R., Dorsey D., et al. PET and P300 relationships in early Alzheimer's disease. Neurobiol Aging 1990, 11:471-476.
27. Mattes R. Food palatability, rheology, and meal patterning. J Parenter Enteral Nutr 2008, 32(5):572-574.
28. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians 1976, 77-121. Grune and Statton, New York. L. Bellak, T.B. Katasu (Eds.).
29. Mokdad A., Marks J., Stroup D., Gerberding J. Actual Causes of Death in the United States, 2000. JAMA: J Am Med Assoc 2004, 291(10):1238-1245.
30. Morgan C.D., Murphy C. Olfactory event-related potentials in Alzheimer's disease. J Int Neuropsychol Soc 2002, 8(6):753-763.
31. Morgan C.D., Nordin S., Murphy C. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J Clin Exp Neuropsychol 1995, 17(5):793-803.
32. Morgan C.D., Geisler M.W., Covington J.W., Polich J., Murphy C. Olfactory P3 in young and older adults. Psychophysiology 1999, 36(3):281-287.
33. Mortensen E.L., Hogh P. A gender difference in the association between ApoE genotype and age-related cognitive decline. Neurology 2001, 57:89-95.
34. Murphy C. Age-related changes in the threshold, psychophysical function and pleasantness of menthol. J Gerontol 1983, 38:217-222.
35. Murphy C. The chemical senses and nutrition in the elderly. J Nutr Elder 2008, 247-265.
36. Murphy C., Anderson J.A., Markison S. Psychophysical assessment of chemosensory disorders in clinical populations. Olfaction and Taste XI 1994, 609-613. Springer Verlag, Tokyo. K. Kurihara, N. Suzuki, H. Ogawa (Eds.).
37. Murphy C., Gilmore M.M., Seery C.S., Salmon D.P., Lasker B.R. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 1990, 11(4):465-469.
38. Murphy C., Morgan C., Geisler M., Wetter S., Covington J., Madowitz M., et al. Olfactory event-related potentials and aging: normative data. Int J Psychophysiol 2000, 36(2):133-145.
39. Murphy C., Nordin S., de Wijk R.A., Cain W.S., Polich J. Olfactory-evoked potentials: assessment of young and elderly, and comparison to psychophysical threshold. Chem Senses 1994, 19(1):47-56.
40. Murphy C., Schubert C.R., Cruickshanks K.J., Klein B.E.K., Klein R., Nondahl D.M. Prevalence of olfactory impairment in older adults. JAMA J Am Med Assoc 2002, 288(18):2307-2312.
41. Murphy C., Solomon E.S., Haase L., Wang M., Morgan C.D. Olfaction in Aging and Alzheimer's disease. Int Symp Olfaction Taste: Ann NY Acad Sci 2009, 1170:647-657.
42. Nijs I., Muris P., Euser A., Franken I. Differences in attention to food and food intake between overweight/obese and normal-weight females under conditions of hunger and satiety. Appetite 2010, 54(2):243-254.
43. Nilsson L., Nilsson E. Overweight and cognition. Scand J Psychol 2009, 50(6):660-667.
44. Noble E.P., Noble R.E., Ritchie T., Syndulko K., Bohlman M.C., Noble L.A., et al. D2 Dopamine receptor gene and obesity. Int J Eat Disorder 1994, 15(3):205-217.
45. Payami H., Motao Z., Montimurro J., Keefe R., McCulloch C., Moses L. One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. Hum Genet 2005, 118(3):322-330.
46. Poehlman E., Toth M. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995, 123(9):673-675.
47. Polich J., Ladish C., Bloom F.E. P300 assessment of early Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1990, 77:179-189.
48. Raji C., Ho A., Becker J., Parikshak N., Lopez O., Kuller L., et al. Brain structure and obesity. Hum Brain Mapp 2009, 31(3):353-364.
49. Richardson B., Vander Woude E., Sudan R., Thompson J., Leopold D. Altered olfactory acuity in the morbidly obese. Obes Surg 2004, 14(7):967-969.
50. Rippon G., Tang M., Lee J., Lantigua R., Medrano M., Mayeux R. Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement. Neurology 2006, 66(1):35-40.
51. Rothemund Y., Preuschhof C., Bohner G., Bauknecht H., Klingebiel R., Flor H., et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007, 37(2):410-421.
52. Saunders A., Trowers M., Shimkets M., Blakemore S., Crowther D., Mansfield T., et al. The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. Biochim Biophys Acta 2000, 1502(1):85-94.
53. Schiffman S. Changes in taste and smell: drug interactions and food preferences. Nutr Rev 1994, 52(8 Pt. 2):S11-S14.
54. Schiffman S., Pasternak M. Decreased discrimination of food odors in the elderly. J Gerontol 1979, 34(1):73-79.
55. Simchen U., Koebnick C., Hoyer S., Issanchou S., Zunft H. Odour and taste sensitivity is associated with body weight and extent of misreporting of body weight. Eur J Clin Nutr 2006, 60(6):698-705.
56. Sørensen L., Møller P., Flint A., Martens M., Raben A. Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Related Metab Disord: J Int Assoc Study Obes 2003, 27(10):1152-1166.
57. Stice E., Spoor S., Bohon C., Small D. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322(5900):449-452.
58. Sundermann E.E., Gilbert P.E., Murphy C. The effect of hormone therapy on olfactory sensitivity is dependent on the apolipoprotein E gentotype. Horm Behav 2008, 54:528-533.
59. Thesen T., Murphy C. Age-related changes in olfactory processing detected with olfactory event-related brain potentials using velopharyngeal closure and natural breathing. Int J Psychophysiol 2000, 40:119-127.
60. Thompson D., Edelsberg J., Colditz G.A., Bird A.P., Oster G. Lifetime health and economic consequences of obesity. Arch Intern Med 1999, 159:2177-2183.
61. Turgeon J., Carr M., Maki P., Mendelsohn M., Wise P. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocr Rev 2006, 27(6):575-605.
62. Volkow N.D., Logan J., Fowler J.S., Wang G., Gur R.C., Wong C., et al. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 2000, 157:75-80.
63. Volkow N., Wang G., Baler R. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 2011, 15(1):37-46.
64. Volkow N., Wang G., Telang F., Fowler J., Thanos P., Logan J., et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage 2008, 42(4):1537-1543.
65. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C., Zhu W., et al. Brain dopamine and obesity. Lancet 2001, 357:354-357.
66. Whitmer R., Gunderson E., Barrett-Connor E., Quesenberry C., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. Brit Med J 2005, 330(7504).
67. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity in midlife increases dementia risk. Geriatrics 2007, 63(5):7.
68. Yang Z., Hall A. The financial burden of overweight and obesity among elderly Americans: the dynamics of weight, longevity, and health care cost. Health Serv Res 2008, 43(3):849-868.
69. Ylikoski R., Ylikoski A., Raininko R., Keskivaara P., Sulkava R., Tilvis R., et al. Cardiovascular diesase, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals. Arch Gero Geriatr 2000, 30(2):115-130.